Insider · CIK 0001320271

Stancic Ana

Reports to the SEC for 6 companies · BRIDGETON, MO

sec.gov

Transactions

Companies

Filings

CIK

0001320271

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-01-08	IMMUNE PHARMACEUTICALS INCStock OptionA Award	Director	AAward	+50K sh	—	—	50,000
2014-11-26	IMMUNE PHARMACEUTICALS INCP Purchase	Director	PPurchase	+8,000 sh	$2.50	+$20K	8,000
2014-11-26	IMMUNE PHARMACEUTICALS INCWarrantP Purchase	Director	PPurchase	+2,000 sh	—	—	2,000
2013-10-10	IMMUNE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2013-10-10	IMMUNE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	Director	JOther	−10K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	Director	JOther	−7,500 sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	Director	JOther	−20K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	Director	JOther	−20K sh	—	—	0
2012-05-14	K-V Pharmaceutical CoOption to PurchaseA Award	Director	AAward	+20K sh	—	—	20,000
2012-01-17	ENZNViskase Holdings, Inc.D Disposition to Issuer	Executive VP, COO, PEO, CFO	DDisposition to Issuer	−45K sh	—	—	15,000
2012-01-17	ENZNViskase Holdings, Inc.A Award	Executive VP, COO, PEO, CFO	AAward	+45K sh	—	—	70,000
2011-11-17	ENZNViskase Holdings, Inc.A Award	Executive VP, COO, PEO, CFO	AAward	+45K sh	—	—	70,000
2011-11-17	ENZNViskase Holdings, Inc. · Employee Stock Option (Right to Buy)A Award	Executive VP, COO, PEO, CFO	AAward	+125K sh	—	—	155,000
2011-11-17	ENZNViskase Holdings, Inc. · Employee Stock Option (Right to Buy)A Award	Executive VP, COO, PEO, CFO	AAward	+125K sh	—	—	125,000
2011-09-08	K-V Pharmaceutical CoOption to PurchaseA Award	Director	AAward	+20K sh	—	—	20,000
2011-07-14	CSBRCHAMPIONS ONCOLOGY, INC. · Common Stock Purchase OptionsA Award	Director	AAward	+50K sh	—	—	50,000
2011-06-08	ENZNViskase Holdings, Inc.A Award	Executive VP, COO, PEO, CFO	AAward	+25K sh	—	—	25,000
2011-06-08	ENZNViskase Holdings, Inc. · Employee Stock Option (Right to Buy)A Award	Executive VP, COO, PEO, CFO	AAward	+30K sh	—	—	30,000
2010-09-07	K-V Pharmaceutical CoOption to PurchaseA Award	Director	AAward	+10K sh	—	—	10,000
2010-06-24	K-V Pharmaceutical CoA Award	Director	AAward	+7,500 sh	—	—	7,500
2010-06-24	K-V Pharmaceutical CoOption to PurchaseA Award	Director	AAward	+7,500 sh	—	—	7,500
2010-02-22	CSBRCHAMPIONS ONCOLOGY, INC. · Common stock Purchase OptionA Award	Director	AAward	+50K sh	—	—	50,000
2009-08-28	CSBRCHAMPIONS ONCOLOGY, INC. · Right to PurchaseA Award	Director	AAward	+50K sh	—	—	50,000
2007-10-01	Omrix Biopharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+8,000 sh	—	—	8,000
2007-10-01	Omrix Biopharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	0
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,666 sh	—	—	2,666
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,667 sh	—	—	5,333
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,667 sh	—	—	8,000
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,667 sh	—	—	2,667
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,667 sh	—	—	5,334
2007-02-15	IMCLONE SYSTEMS INCRESTRICTED STOCK UNITA Award	SVP, Finance	AAward	+2,666 sh	—	—	8,000
2006-07-10	IMCLONE SYSTEMS INCSTOCK OPTION (RIGHT TO BUY)A Award	SVP, Finance	AAward	+3,334 sh	—	—	3,334
2006-07-10	IMCLONE SYSTEMS INCSTOCK OPTION (RIGHT TO BUY)A Award	SVP, Finance	AAward	+3,333 sh	—	—	6,667
2006-07-10	IMCLONE SYSTEMS INCSTOCK OPTION (RIGHT TO BUY)A Award	SVP, Finance	AAward	+3,333 sh	—	—	10,000

Recent filings

Accepted (ET)
Jan 124
IMMUNE PHARMACEUTICALS INC0001144204-15-001863
SEC(opens sec.gov)
Dec 34
IMMUNE PHARMACEUTICALS INC0001144204-14-072161
SEC(opens sec.gov)
Oct 154
IMMUNE PHARMACEUTICALS INC0001208261-13-000018
SEC(opens sec.gov)
Sep 274
K-V Pharmaceutical Co0001320271-13-000001
SEC(opens sec.gov)
May 164
Stancic Ana0001260836-12-000001
SEC(opens sec.gov)
Jan 194
Stancic Ana0000930413-12-000226
SEC(opens sec.gov)
Jan 194/A
Stancic Ana0000930413-12-000231
SEC(opens sec.gov)
Nov 214
Stancic Ana0000930413-11-007514
SEC(opens sec.gov)
Sep 124
Stancic Ana0001140361-11-045453
SEC(opens sec.gov)
Jul 184
Stancic Ana0001116354-11-000008
SEC(opens sec.gov)
Jun 94
Stancic Ana0000930413-11-004317
SEC(opens sec.gov)
Oct 124/A
Stancic Ana0001140361-10-040782
SEC(opens sec.gov)

Companies

Address

1 CORPORATE WOODS DRIVE

BRIDGETON, MO, 63044